1. Home
  2. RACE vs TAK Comparison

RACE vs TAK Comparison

Compare RACE & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ferrari N.V.

RACE

Ferrari N.V.

HOLD

Current Price

$344.10

Market Cap

59.9B

ML Signal

HOLD

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$16.32

Market Cap

52.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RACE
TAK
Founded
1947
1781
Country
Italy
Japan
Employees
N/A
47455
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.9B
52.4B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
RACE
TAK
Price
$344.10
$16.32
Analyst Decision
Strong Buy
Analyst Count
9
0
Target Price
$477.86
N/A
AVG Volume (30 Days)
518.6K
2.8M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
1.26%
3.24%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.91
$0.16
Revenue Next Year
$7.51
$1.22
P/E Ratio
$34.59
$41.25
Revenue Growth
N/A
N/A
52 Week Low
$312.51
$12.99
52 Week High
$519.10
$18.90

Technical Indicators

Market Signals
Indicator
RACE
TAK
Relative Strength Index (RSI) 54.57 36.05
Support Level $325.30 $16.24
Resistance Level $380.68 $16.48
Average True Range (ATR) 6.96 0.23
MACD 0.87 0.05
Stochastic Oscillator 99.48 36.70

Price Performance

Historical Comparison
RACE
TAK

About RACE Ferrari N.V.

Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2025, the company sold 13,640 vehicles at an average price over EUR 520,000 with more than 80% of its vehicles being sold to existing Ferrari clients. Eighty-four percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2025, the Europe, Middle East, and Africa region accounted for 49% of revenue, the Americas was 32%, mainland China, Hong Kong, and Taiwan was 7%, and the rest of Asia was 12%.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: